Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
R

Regenicin Inc
OTC:RGIN

Watchlist Manager
Regenicin Inc
OTC:RGIN
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $153
Write Note Create Alert Ask AI

Bankruptcy Probability

Regenicin Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .

We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.

Probability of Bankruptcy
LOCKED
Unlock

Financial Position

Cash & Short-Term Investments
+
3Y
+790 500%
5Y
-
10Y
+59 195%
Long-Term Investments
+
3Y
-
5Y
-
10Y
-
Debt
+
3Y
+16%
5Y
+107%
10Y
+13%

Solvency Ratios

Solvency Ratios Comparison
Regenicin Inc Competitors

Country Company Market Cap D/E D/A Interest
Coverage 		Altman
Z-Score 		Quick
Ratio 		Current
Ratio 		Cash
Ratio
US
Regenicin Inc
OTC:RGIN
153 USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
220.3B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
499.3B CNY
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
51B EUR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Revolution Medicines Inc
NASDAQ:RVMD
44.1B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
CH
BeOne Medicines AG
SSE:688235
235.9B CNY
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
DE
Biontech SE
NASDAQ:BNTX
24.3B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
DK
Genmab A/S
CSE:GMAB
142.1B DKK
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
DE
InflaRx NV
NASDAQ:IFRX
252m USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Medpace Holdings Inc
NASDAQ:MEDP
16.7B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
DK
Ascendis Pharma A/S
NASDAQ:ASND
15B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Continue RGIN Research

Summary
RGIN intrinsic value, competitors valuation, and company profile.
DCF Valuation
RGIN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RGIN stock valuation using valuation multiples.
Wall St Estimates
RGIN price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RGIN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Discover More
Is Regenicin Inc at risk of bankruptcy?

Regenicin Inc's probability of bankruptcy is Hidden .

The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.

How much debt does Regenicin Inc have?

As of the latest report, Regenicin Inc has total debt of 642.9k USD. This includes both short-term (642.9k USD) and long-term (0 USD) debt.

You can find a full breakdown on its Balance Sheet.

Back to Top
ALPHA SPREAD
Follow us
Join 359,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.